scholarly article | Q13442814 |
P50 | author | Thomas Gress | Q59785425 |
Magnus von Knebel Doeberitz | Q87739754 | ||
Hans-Joachim Gabius | Q38321355 | ||
Sabine André | Q40339401 | ||
Bertram Wiedenmann | Q41604544 | ||
P2093 | author name string | Jürgen Kopitz | |
Shin-Ichiro Nishimura | |||
Malte Buchholz | |||
Hiroaki Nakagawa | |||
Kisaburo Deguchi | |||
Wolfgang Kemmner | |||
Stefan Rosewicz | |||
Corina Böck | |||
Hugo Sanchez-Ruderisch | |||
Katharia M Detjen | |||
Pia Forberich | |||
P2860 | cites work | Effect of 5-azacytidine and galectin-1 on growth and differentiation of the human b lymphoma cell line bl36 | Q24805197 |
Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT Method | Q25938999 | ||
Overexpression of pRB in human pancreatic carcinoma cells: function in chemotherapy-induced apoptosis | Q27824780 | ||
Transcriptional regulation of the human beta-1,4-galactosyltransferase V gene in cancer cells: essential role of transcription factor Sp1 | Q28272913 | ||
Human galectin-2: novel inducer of T cell apoptosis with distinct profile of caspase activation | Q28281057 | ||
Beta1,4-galactosyltransferase V functions as a positive growth regulator in glioma | Q28295914 | ||
Polylactosamine synthesis and branch formation of N-glycans in beta1,4-galactosyltransferase-1-deficient mice | Q28507513 | ||
A focused microarray approach to functional glycomics: transcriptional regulation of the glycome | Q30800594 | ||
Determination of modulation of ligand properties of synthetic complex-type biantennary N-glycans by introduction of bisecting GlcNAc in silico, in vitro and in vivo. | Q31033747 | ||
Carbohydrate-carbohydrate binding of ganglioside to integrin alpha(5) modulates alpha(5)beta(1) function. | Q31705382 | ||
Deletion of mouse embryo fibroblast N-acetylglucosaminyltransferase V stimulates alpha5beta1 integrin expression mediated by the protein kinase C signaling pathway | Q45198893 | ||
Synthesis of poly-N-acetyllactosamine in core 2 branched O-glycans. The requirement of novel beta-1,4-galactosyltransferase IV and beta-1,3-n-acetylglucosaminyltransferase | Q46525727 | ||
Galectin-1 interacts with the {alpha}5{beta}1 fibronectin receptor to restrict carcinoma cell growth via induction of p21 and p27. | Q46654963 | ||
Carbohydrate chain of ganglioside GM1 as a ligand: identification of the binding strategies of three 15 mer peptides and their divergence from the binding modes of growth-regulatory galectin-1 and cholera toxin | Q46789100 | ||
Complex N-glycans are the major ligands for galectin-1, -3, and -8 on Chinese hamster ovary cells | Q46828658 | ||
Galectin-8 binds specific beta1 integrins and induces polarized spreading highlighted by asymmetric lamellipodia in Jurkat T cells | Q46861486 | ||
The acceptor substrate specificity of human beta4-galactosyltransferase V indicates its potential function in O-glycosylation | Q48197881 | ||
Galectin-1 modulates human glioblastoma cell migration into the brain through modifications to the actin cytoskeleton and levels of expression of small GTPases | Q48543365 | ||
Influence of type of linkage and spacer on the interaction of beta-galactoside-binding proteins with immobilized affinity ligands | Q48759283 | ||
Galectin-1 is highly expressed in human gliomas with relevance for modulation of invasion of tumor astrocytes into the brain parenchyma | Q48958266 | ||
Activation of human endothelial cells by tumor necrosis factor-α results in profound changes in the expression of glycosylation-related genes | Q57261985 | ||
Glycosyldisulfides from dynamic combinatorial libraries as O-glycoside mimetics for plant and endogenous lectins: their reactivities in solid-phase and cell assays and conformational analysis by molecular dynamics simulations | Q33247129 | ||
Discovery of galectin ligands in fully randomized combinatorial one-bead-one-compound (glyco)peptide libraries | Q33263168 | ||
Eukaryotic glycosylation: whim of nature or multipurpose tool? | Q33608239 | ||
A secreted type of beta 1,6-N-acetylglucosaminyltransferase V (GnT-V) induces tumor angiogenesis without mediation of glycosylation: a novel function of GnT-V distinct from the original glycosyltransferase activity | Q34116588 | ||
The asialoglycoprotein receptor clears glycoconjugates terminating with sialic acid alpha 2,6GalNAc | Q34144756 | ||
Glycohistochemistry: the why and how of detection and localization of endogenous lectins. | Q34205805 | ||
Homodimeric galectin-7 (p53-induced gene 1) is a negative growth regulator for human neuroblastoma cells | Q34247078 | ||
Expression of N-acetylglucosaminyltransferase v is associated with prognosis and histology in non-small cell lung cancers | Q34304814 | ||
Genetic complementation reveals a novel human congenital disorder of glycosylation of type II, due to inactivation of the Golgi CMP-sialic acid transporter | Q34372978 | ||
Elevated beta1,4-galactosyltransferase I in highly metastatic human lung cancer cells. Identification of E1AF as important transcription activator | Q34378390 | ||
Transcriptional regulation of N-acetylglucosaminyltransferase V by the src oncogene | Q34433644 | ||
N-acetylglucosaminyltransferase V and beta1-6 branching N-linked oligosaccharides are associated with good prognosis of patients with bladder cancer | Q34517727 | ||
Plant lectins: occurrence, biochemistry, functions and applications. | Q34959357 | ||
Leukocyte adhesion deficiency II: therapy and genetic defect | Q35022314 | ||
A genetic approach to Mammalian glycan function | Q35099563 | ||
Chemical biology of the sugar code | Q35790497 | ||
The glycan code of the endoplasmic reticulum: asparagine-linked carbohydrates as protein maturation and quality-control tags | Q36153965 | ||
GalNAc-alpha-O-benzyl inhibits NeuAcalpha2-3 glycosylation and blocks the intracellular transport of apical glycoproteins and mucus in differentiated HT-29 cells. | Q36255476 | ||
Mitogenic leukoagglutinin from Phaseolus vulgaris binds to a pentasaccharide unit in N-acetyllactosamine-type glycoprotein glycans | Q36285557 | ||
A novel function for the tumor suppressor p16(INK4a): induction of anoikis via upregulation of the alpha(5)beta(1) fibronectin receptor | Q36293774 | ||
Cell surface glycans: the why and how of their functionality as biochemical signals in lectin-mediated information transfer | Q36393405 | ||
Cell surface alpha 2,6 sialylation affects adhesion of breast carcinoma cells | Q38289793 | ||
Negative regulation of neuroblastoma cell growth by carbohydrate-dependent surface binding of galectin-1 and functional divergence from galectin-3. | Q38299041 | ||
Interaction profile of galectin-5 with free saccharides and mammalian glycoproteins: probing its fine specificity and the effect of naturally clustered ligand presentation. | Q38314956 | ||
alpha2,3/alpha2,6-Sialylation of N-glycans: non-synonymous signals with marked developmental regulation in bovine reproductive tracts | Q38317619 | ||
Galectins bind to the multivalent glycoprotein asialofetuin with enhanced affinities and a gradient of decreasing binding constants | Q38321186 | ||
Gene expression profiling of mouse postnatal cerebellar development using oligonucleotide microarrays designed to detect differences in glycoconjugate expression | Q38325711 | ||
Introduction of extended LEC14-type branching into core-fucosylated biantennary N-glycan | Q38328250 | ||
The her-2/neu oncogene stimulates the transcription of N-acetylglucosaminyltransferase V and expression of its cell surface oligosaccharide products | Q38331805 | ||
Rapid cell senescence-associated changes in galactosylation of N-linked oligosaccharides in human lung adenocarcinoma A549 cells | Q38340807 | ||
Unique conformer selection of human growth-regulatory lectin galectin-1 for ganglioside GM1 versus bacterial toxins | Q38346834 | ||
Galectin-3 precipitates as a pentamer with synthetic multivalent carbohydrates and forms heterogeneous cross-linked complexes | Q38346878 | ||
First demonstration of differential inhibition of lectin binding by synthetic tri- and tetravalent glycoclusters from cross-coupling of rigidified 2-propynyl lactoside. | Q38347052 | ||
Animal lectins | Q38348817 | ||
Ras oncogene directs expression of a differentially sialylated, functionally altered β1 integrin | Q38349173 | ||
Comparative cross-linking activities of lactose-specific plant and animal lectins and a natural lactose-binding immunoglobulin G fraction from human serum with asialofetuin | Q38350784 | ||
Mucin synthesis. Conversion of R1-beta 1-3Gal-R2 to R1-beta 1-3(GlcNAc beta 1-6)Gal-R2 and of R1-beta 1-3GalNAc-R2 to R1-beta 1-3(GlcNAc beta 1-6)GalNAc-R2 by a beta 6-N-acetylglucosaminyltransferase in pig gastric mucosa | Q38350817 | ||
Malignant cell glycoproteins and glycolipids | Q38613949 | ||
Branching mode in complex-type triantennary N-glycans as regulatory element of their ligand properties | Q40297187 | ||
Down-regulation of the expression of beta1,4-galactosyltransferase V promotes integrin beta1 maturation | Q40299989 | ||
Aberrant expression of N-acetylglucosaminyltransferase-IVa and IVb (GnT-IVa and b) in pancreatic cancer | Q40325695 | ||
High expression of N-acetylglucosaminyltransferase V in favorable neuroblastomas: Involvement of its effect on apoptosis | Q40331560 | ||
Hypersialylation of beta1 integrins, observed in colon adenocarcinoma, may contribute to cancer progression by up-regulating cell motility | Q40414546 | ||
Ras oncogene induces beta-galactoside alpha2,6-sialyltransferase (ST6Gal I) via a RalGEF-mediated signal to its housekeeping promoter | Q40517981 | ||
Galectin-3 augments K-Ras activation and triggers a Ras signal that attenuates ERK but not phosphoinositide 3-kinase activity | Q40543716 | ||
Transfection of 2,6 and 2,3-sialyltransferase genes and GlcNAc-transferase genes into human glioma cell line U-373 MG affects glycoconjugate expression and enhances cell death | Q40547157 | ||
Persubstituted cyclodextrin-based glycoclusters as inhibitors of protein-carbohydrate recognition using purified plant and mammalian lectins and wild-type and lectin-gene-transfected tumor cells as targets | Q40597683 | ||
Regulation on the expression and N-glycosylation of integrins by N-acetylglucosaminyltransferase V | Q40629726 | ||
The ST6Gal I sialyltransferase selectively modifies N-glycans on CD45 to negatively regulate galectin-1-induced CD45 clustering, phosphatase modulation, and T cell death | Q40681367 | ||
Hyposialylation of integrins stimulates the activity of myeloid fibronectin receptors | Q40721464 | ||
FosB gene products trigger cell proliferation and morphological alteration with an increased expression of a novel processed form of galectin-1 in the rat 3Y1 embryo cell line. | Q40735153 | ||
Occurrence of oligosialic acids on integrin alpha 5 subunit and their involvement in cell adhesion to fibronectin | Q40797420 | ||
Galectins-1 and -3 and their ligands in tumor biology. Non-uniform properties in cell-surface presentation and modulation of adhesion to matrix glycoproteins for various tumor cell lines, in biodistribution of free and liposome-bound galectins and i | Q40930082 | ||
Down-regulation of beta1,4-galactosyltransferase gene expression by cell-cycle suppressor gene p16. | Q40975647 | ||
Galectin-1 is a major receptor for ganglioside GM1, a product of the growth-controlling activity of a cell surface ganglioside sialidase, on human neuroblastoma cells in culture | Q41036890 | ||
A crucial role for T-bet in selectin ligand expression in T helper 1 (Th1) cells | Q42090258 | ||
New aspects of galectin functionality in nuclei of cultured bone marrow stromal and epidermal cells: biotinylated galectins as tool to detect specific binding sites | Q42453087 | ||
Determination of structural and functional overlap/divergence of five proto-type galectins by analysis of the growth-regulatory interaction with ganglioside GM1 in silico and in vitro on human neuroblastoma cells | Q42639630 | ||
Evidence for stimulation of tumor proliferation in cell lines and histotypic cultures by clinically relevant low doses of the galactoside-binding mistletoe lectin, a component of proprietary extracts | Q43570944 | ||
Cutting edge: differential requirements for Stat4 in expression of glycosyltransferases responsible for selectin ligand formation in Th1 cells | Q43664728 | ||
Germ cell survival through carbohydrate-mediated interaction with Sertoli cells | Q43845917 | ||
Lectin localization in human nerve by biochemically defined lectin-binding glycoproteins, neoglycoprotein and lectin-specific antibody | Q44041022 | ||
Galectin-1(L11A) predicted from a computed galectin-1 farnesyl-binding pocket selectively inhibits Ras-GTP. | Q44883110 | ||
Loss of disialyl Lewis(a), the ligand for lymphocyte inhibitory receptor sialic acid-binding immunoglobulin-like lectin-7 (Siglec-7) associated with increased sialyl Lewis(a) expression on human colon cancers. | Q44961886 | ||
Growth-regulatory human galectin-1: crystallographic characterisation of the structural changes induced by single-site mutations and their impact on the thermodynamics of ligand binding | Q45100720 | ||
Dimeric galectin-1 binds with high affinity to alpha2,3-sialylated and non-sialylated terminal N-acetyllactosamine units on surface-bound extended glycans. | Q45158458 | ||
P433 | issue | 13 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | pancreatic carcinoma | Q18556536 |
P304 | page(s) | 3233-3256 | |
P577 | publication date | 2007-05-29 | |
P1433 | published in | FEBS Journal | Q1388041 |
P1476 | title | Tumor suppressor p16INK4a--modulator of glycomic profile and galectin-1 expression to increase susceptibility to carbohydrate-dependent induction of anoikis in pancreatic carcinoma cells | |
P478 | volume | 274 |
Q33810026 | A regulatory network of two galectins mediates the earliest steps of avian limb skeletal morphogenesis. |
Q47864390 | Adhesion/growth-regulatory galectins in the human eye: localization profiles and tissue reactivities as a standard to detect disease-associated alterations |
Q38004594 | Beyond glycoproteins as galectin counterreceptors: tumor-effector T cell growth control via ganglioside GM1 [corrected]. |
Q46505356 | Cell-type-specific expression of murine multifunctional galectin-3 and its association with follicular atresia/luteolysis in contrast to pro-apoptotic galectins-1 and -7. |
Q42837584 | Clicked and long spaced galactosyl- and lactosylcalix[4]arenes: new multivalent galectin-3 ligands |
Q36304002 | Clinical implication of the serum galectin-1 expression in epithelial ovarian cancer patients |
Q53270597 | Colonic carcinogenesis along different genetic routes: glycophenotyping of tumor cases separated by microsatellite instability/stability. |
Q51768317 | Combining carbohydrate substitutions at bioinspired positions with multivalent presentation towards optimising lectin inhibitors: case study with calixarenes. |
Q38312051 | Conformational selection in glycomimetics: human galectin-1 only recognizes syn-Ψ-type conformations of β-1,3-linked lactose and its C-glycosyl derivative. |
Q38071660 | Context-dependent multifunctionality of galectin-1: a challenge for defining the lectin as therapeutic target |
Q41334598 | Contribution of galectin-1, a glycan-binding protein, to gastrointestinal tumor progression |
Q50847552 | Copy-number variation of functional galectin genes: studying animal galectin-7 (p53-induced gene 1 in man) and tandem-repeat-type galectins-4 and -9. |
Q38337529 | Cyclic neoglycodecapeptides: how to increase their inhibitory activity and selectivity on lectin/toxin binding to a glycoprotein and cells |
Q45988156 | Defining the potential of aglycone modifications for affinity/selectivity enhancement against medically relevant lectins: synthesis, activity screening, and HSQC-based NMR analysis. |
Q46095235 | Detection of galectin-3 in patients with inflammatory bowel diseases: new serum marker of active forms of IBD? |
Q34676070 | Emerging role of alpha2,6-sialic acid as a negative regulator of galectin binding and function |
Q27685442 | Fine-tuning of prototype chicken galectins: structure of CG-2 and structure-activity correlations |
Q88580977 | From glycophenotyping by (plant) lectin histochemistry to defining functionality of glycans by pairing with endogenous lectins |
Q42688469 | Functional interplay between ganglioside GM1 and cross-linking galectin-1 induces axon-like neuritogenesis via integrin-based signaling and TRPC5-dependent Ca²⁺ influx |
Q30436202 | Galectin fingerprinting in naso-sinusal diseases |
Q38294225 | Galectin-1 Couples Glycobiology to Inflammation in Osteoarthritis through the Activation of an NF-κB-Regulated Gene Network |
Q38339024 | Galectin-1 sensitizes carcinoma cells to anoikis via the fibronectin receptor α5β1-integrin. |
Q89207834 | Galectin-8 induces functional disease markers in human osteoarthritis and cooperates with galectins-1 and -3 |
Q33902518 | Galectins as tools for glycan mapping in histology: comparison of their binding profiles to the bovine zona pellucida by confocal laser scanning microscopy |
Q39052321 | Galectins: their network and roles in immunity/tumor growth control |
Q35180105 | Ganglioside GM1 deficiency in effector T cells from NOD mice induces resistance to regulatory T-cell suppression |
Q37690232 | Glycophenotyping of osteoarthritic cartilage and chondrocytes by RT-qPCR, mass spectrometry, histochemistry with plant/human lectins and lectin localization with a glycoprotein |
Q57825182 | Human Galectins Induce Conversion of Dermal Fibroblasts into Myofibroblasts and Production of Extracellular Matrix: Potential Application in Tissue Engineering and Wound Repair |
Q61454627 | Human galectins as sensors for apoptosis/necrosis-associated surface changes of granulocytes and lymphocytes |
Q57901365 | Human osteoarthritic knee cartilage: fingerprinting of adhesion/growth-regulatory galectins in vitro and in situ indicates differential upregulation in severe degeneration |
Q33605492 | Hydrodynamic properties of human adhesion/growth-regulatory galectins studied by fluorescence correlation spectroscopy |
Q35723085 | Hypoxia Up-Regulates Galectin-3 in Mammary Tumor Progression and Metastasis |
Q37809484 | In search of a solution to the sphinx-like riddle of GM1. |
Q53682346 | Increased expression of distinct galectins in multiple sclerosis lesions. |
Q37412929 | Inhibition of human retinal pigment epithelial cell attachment, spreading, and migration by the human lectin galectin-1. |
Q47677002 | Integrin β1 is bound to galectin-1 in human trophoblast |
Q38180146 | Introduction to glycopathology: the concept, the tools and the perspectives |
Q38332609 | Lectins: getting familiar with translators of the sugar code |
Q39045114 | Lipid glycosylation: a primer for histochemists and cell biologists |
Q42507266 | Loss of adhesion/growth-regulatory galectin-9 from squamous cell epithelium in head and neck carcinomas |
Q26749071 | Multivalent Carbohydrate-Lectin Interactions: How Synthetic Chemistry Enables Insights into Nanometric Recognition |
Q27688879 | Natural single amino acid polymorphism (F19Y) in human galectin-8: detection of structural alterations and increased growth-regulatory activity on tumor cells |
Q50564014 | Network monitoring of adhesion/growth-regulatory galectins: localization of the five canonical chicken proteins in embryonic and maturing bone and cartilage and their introduction as histochemical tools. |
Q38978059 | Open Wound Healing In Vivo: Monitoring Binding and Presence of Adhesion/Growth-Regulatory Galectins in Rat Skin during the Course of Complete Re-Epithelialization |
Q41873777 | Preliminary X-ray crystallographic analysis of an engineered variant of human chimera-type galectin-3 with a shortened N-terminal domain. |
Q33791981 | Proteomics in pancreatic cancer research |
Q41016662 | Regulatory Impact of Amniotic Membrane Transplantation on Presence of Adhesion/Growth-Regulatory Galectins-1 and -7 in Corneal Explants from Acanthamoeba Keratitis Patients: Clinical Note. |
Q38288649 | Sialylation of beta1 integrins blocks cell adhesion to galectin-3 and protects cells against galectin-3-induced apoptosis |
Q57664399 | Smooth muscle actin-expressing stromal fibroblasts in head and neck squamous cell carcinoma: Increased expression of galectin-1 and induction of poor prognosis factors |
Q35559685 | Structural aspects of binding of α-linked digalactosides to human galectin-1 |
Q41183639 | Structural significance of galectin design: impairment of homodimer stability by linker insertion and partial reversion by ligand presence. |
Q38766179 | Sweet complementarity: the functional pairing of glycans with lectins |
Q33928742 | Symmetric dithiodigalactoside: strategic combination of binding studies and detection of selectivity between a plant toxin and human lectins. |
Q44484616 | Synthetic polyamine BPA-C8 inhibits TGF-β1-mediated conversion of human dermal fibroblast to myofibroblasts and establishment of galectin-1-rich extracellular matrix in vitro |
Q51237398 | Teaming up synthetic chemistry and histochemistry for activity screening in galectin-directed inhibitor design. |
Q38096239 | The third dimension of reading the sugar code by lectins: design of glycoclusters with cyclic scaffolds as tools with the aim to define correlations between spatial presentation and activity. |
Q35904166 | Thermodynamic Switch in Binding of Adhesion/Growth Regulatory Human Galectin-3 to Tumor-Associated TF Antigen (CD176) and MUC1 Glycopeptides. |
Q54389574 | Toward comprehensive analysis of the galectin network in chicken: unique diversity of galectin-3 and comparison of its localization profile in organs of adult animals to the other four members of this lectin family. |
Q54657364 | Tumor suppressor p16 INK4a: Downregulation of galectin-3, an endogenous competitor of the pro-anoikis effector galectin-1, in a pancreatic carcinoma model. |
Q35890610 | Tumor-Associated Glycans and Immune Surveillance |
Q54486460 | Tumour suppressor p16(INK4a) - anoikis-favouring decrease in N/O-glycan/cell surface sialylation by down-regulation of enzymes in sialic acid biosynthesis in tandem in a pancreatic carcinoma model. |
Q39264263 | Upregulation of IL-6, IL-8 and CXCL-1 production in dermal fibroblasts by normal/malignant epithelial cells in vitro: Immunohistochemical and transcriptomic analyses. |
Q37296108 | VHL-dependent regulation of a β-dystroglycan glycoform and glycogene expression in renal cancer |
Q46695812 | Versatile strategy for the synthesis of biotin-labelled glycans, their immobilization to establish a bioactive surface and interaction studies with a lectin on a biochip |
Search more.